Related Experiment Video
Updated: Apr 27, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
Published on: May 11, 2015
Shared medical appointments in pulmonary hypertension
Franck F Rahaghi1, Veronica L Chastain1, Rosanna Benavides1
1Department of Pulmonary and Critical Care, Cleveland Clinic Florida, Weston, Florida, USA.
Shared medical appointments (SMAs) effectively support pulmonary hypertension (PH) patients, enhancing disease understanding and satisfaction. This model integrates peer support and addresses emotional needs, proving beneficial for PH care.
Area of Science:
- Cardiology
- Pulmonology
- Health Services Research
Background:
- Pulmonary hypertension (PH) requires comprehensive patient management.
- Traditional one-on-one appointments may not fully address patient education and psychosocial needs.
Purpose of the Study:
- To adapt the shared medical appointment (SMA) model for pulmonary hypertension (PH) patient care.
- To evaluate patient satisfaction and outcomes within the adapted SMA model.
Main Methods:
- An SMA team comprising a PH specialist, nurse, and fellow conducted group sessions.
- Sessions included a 30-minute educational presentation followed by individual patient visits with group interaction.
- Fifty-three PH patients and family members were invited and encouraged to attend.
Main Results:
- 84% of patients expressed willingness to attend future SMAs.
- 98% rated the care as excellent to very good.
- 92% reported improved understanding of PH and treatment; 59% preferred group visits.
- 25% considered changing treatment based on peer discussions; privacy concerns were minimal (76% before, 88% after).
Conclusions:
- The SMA model enhances PH patient understanding of their disease and treatment.
- It successfully integrates peer support, social interaction, and emotional support.
- The model shows potential applicability to other rare pulmonary diseases.
More Related Videos
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Other Pulmonary Disorders
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

